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NMRce (NMR) spectroscopy was used to investigate the relationship between
oxidative stress experienced by RBCs and their phospholipid content and shedding. Using 1H-NMR, we
demonstrated a higher lactate/pyruvate ratio, an indicator of oxidative stress, in normal RBCs treated with
oxidants (t-butylhydroxyperoxide and H2O2) as well as in β-thalassemic RBCs. Using
31P-NMR, we found
30% more phosphatidylcholine (PC), and unexpectedly, 35% less phosphatidylserine (PS) in the thalassemic
RBCs. PS was decreased by treatment with oxidants and increased by anti-oxidants (vitamin C and N-acetyl
cysteine); PC showed the opposite behavior. Thalassemic RBCs incubated in phosphate buffered saline
produced more PS in the supernatant than normal RBCs. Anti-oxidants reduced the PS in the supernatant
while oxidants increased it. Plasma of thalassemic patients contained 2.6-fold and 1.8-fold more PS and PC,
respectively, than normal plasma. These results indicate that the decreased PS in RBCs resulted from
increased shedding. The nature of the shed PS was studied by purifying and analyzing membranous
microparticles from the plasma and RBC supernatants. More PS was found in microparticles puriﬁed from
thalassemic plasma and RBC supernatants (5.6- and 4.8-fold, respectively) than in their normal
counterparts. However, the bulk (80–90%) of the shed PS was not associated with microparticles. The
signiﬁcance of PS shedding for RBC survival needs further clariﬁcation.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
The asymmetric distribution of membrane phospholipids (PLs) is
common to all cells, including the red blood cells (RBCs) [1].
Aminophospholipids such as phosphatidylserine (PS) are mainly
localized in the cytoplasmic leaﬂet of the membrane whereas lipids
with the choline head such as phosphatidylcholine (PC) are mainly
present in the outer leaﬂet [2]. Changes in this asymmetry are one of
the hallmarks of apoptosis of nucleated cells. For example, PS ﬂip-ﬂops
to the external membrane leaﬂet as part of the multiple cellular
changes that occur following induction of apoptosis. Although mature
anucleated RBCs do not undergo a classical pattern of apoptosis, upon
trauma or aging they present changes in membrane asymmetry that
include PS externalization [3,4]. Externalization of PS is one of the
changes thought to cause RBC removal from the circulation by
phagocytosis by macrophages of the reticulo-endothelial system. Thismicroparticles; NAC, N-acetyl
tic Resonance; PBS, phosphate
hatidylethanolamine; PE-plas,
dylinositol; PL, phospholipids;
rd deviation; TMP, Trimethyl-
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ll rights reserved.process, termed “extra-vascular hemolysis”, occurs under physiolo-
gical conditions during RBC ageing (senescence) and it is increased
in certain pathological conditions such as the hereditary hemolytic
anemias, β-thalassemia and sickle-cell anemia, collectively named
β-hemoglobinopathies [1].
Oxidative stress is among the causes of PS externalization on RBCs
[5]. The oxidative stress is increased by various environmental factors,
such as pollution, radiation, herbicides, ultraviolet or radioactive
radiation and cigarette smoke [6,7], as well as in a variety of
pathophysiological conditions such as inﬂammation, immunological
disorders, hypoxia, hyperoxia, metabolism of drugs or alcohol, and
exposure to, and deﬁciency in antioxidant vitamins [8]. In the β-
hemoglobinopathies, although the primary defects are mutations in
the globin genes causing reduced or absence of β-globin chains or the
production of abnormal β-globin, oxidative stress is thought to
mediate part of the damage to the RBCs, and particularly to its
membrane, including PS externalization [9–11].
In the present study, we used Nuclear Magnetic Resonance (NMR)
spectroscopy to analyze normal and thalassemic RBCs in order to
study the relationship between oxidative stress and their PL content
and shedding. Using established 1H and 31P NMR procedures [12,13],
we measured absolute concentrations of metabolites in aqueous and
organic extracts [14–16]. Using 1H NMR, we demonstrated a higher
lactate/pyruvate ratio in thalassemic RBCs, conﬁrming their state of
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contents of various PLs and found more PC, but unexpectedly, less PS
in thalassemic RBCs than in normal RBCs. We hypothesized that the
decrease in total cellular PS content is the result of shedding of PS from
the external membrane, either as free PS moieties or as part of
membrane vesicles, microparticles (MPs). NMR analysis of blood
plasma obtained from normal and thalassemic donors indicated an
increased PS and PC contents in the latter plasma. In vitro incubation
of RBCs produced much higher PS in supernatants derived from
thalassemic RBCs compared with those of normal RBCs. The results
show that oxidative stress causes RBCs to shed their PS; some of this
shed PS was found in membranous MPs whereas the majority was not
associated with MPs and was probably bound to soluble proteins. The
signiﬁcance of PS shedding on RBC survival under physiological and
pathological conditions and the exact mechanisms involved warrant
further study.
2. Materials and methods
2.1. Materials
Phosphatidycholine (PC), phosphatidylethanolamine (PE), phos-
phatidylethanolamine-plasmalogen (PE-plas), phosphatidylserine
(PS), phosphatiylinositol (PI), sphingomyelin (SM), benzidine,
Chelex-100, t-butylhydroxyperoxide (BHP), H2O2, vitamin C (Vit. C),
N-acetyl cysteine (NAC), trimethylphosphate (TMP), tetraethylam-
monium chloride, N-ethylmaleimide (NEM) deutrated chloroform
(CDCl3) and D2O were all purchased from Fluka/Sigma-Aldrich
Israel Ltd (Rehovot, Israel). HPLC grade methanol and chloroform
were purchased from GT Baker (Phillipsburg, NJ).
2.2. RBCs, plasma and microparticles
Peripheral blood samples of both normal donors and β-thalasse-
mic patients were obtained from counting vials after all diagnostic
laboratory tests were completed. Informed consentwas obtained in all
cases. The relevant clinical aspects of these patients were recently
summarized [17]. All patients are treated by frequent blood transfu-
sions; blood samples were obtained prior to transfusion, i.e., at least 3
weeks following the previous transfusion.
Blood (2.5 ml) was centrifuged for 5 min at 200 g. RBCs were
washed twice, resuspended in phosphate buffered saline (PBS) and
counted microscopically using a hemocytometer. The plasma was
centrifuged for 10 min at 3000 g to remove remaining leukocytes,
platelets and cell debris. MPs were puriﬁed from the plasma and RBC
supernatants (about 5×109 RBCs) by 1 h centrifugation at 100,000 g,
4 °C [18].
2.3. Extractions
The extraction was performed using modiﬁed Folch method [19]
that has been previously used for PLs quantiﬁcation [20]. Six volumes
of cold methanol:chloroform (1:2) mixture were added to one volume
of ice-cold sample containing about 1×109 RBCs, stirred and ﬁltered
(ﬁberglass ﬁlter, 0.2 μ, Whatman, Brentford, UK). Then, 4 volumes of
0.1 M KCl were added, and the mixture was left overnight at 4 °C for
phase separation.
The upper (hydrophilic) phase was centrifuged for 15 min at
20,000 g to remove salts, and then mixed with 0.2 g Chelex 100 (a
paramagnetic ion chelator) and stirred for 1 h at 4 °C. The extract was
ﬁltered to remove Chelex 100, lyophilized and stored at −70 °C. Before
analysis, the dry extract was dissolved in D2O, transferred to a 5 mm
NMR tube and analyzed for lactate and pyruvate contents.
The lower (hydrophobic) phase was evaporated at 35 °C and
phospholipid sample preparation for NMR analysis was performed
according to the hydrated chloroform/methanol solvent system[15,21]. The precipitate was dissolved in CDCl3 (0.7 ml) and
transferred to a 5 mm NMR tube. A 0.24 ml of freshly prepared
solution of K4-EDTA (a paramagnetic ion chelator, 0.2 M) and
methanol (1:4 V/V) was added, the mixture stirred and left
overnight for phase separation. The lower (hydrophobic) phase
was further analyzed for the PL content.
2.4. NMR spectroscopy
Spectra were obtained with a Varian Inova500 spectrometer
equipped with 11.74 T 51-mm Bore Oxford Magnet (Varian Medical
Systems, Palo Alto, CA), operating at 202.4 MHz for 31P and 500 MHz
for 1H. A 5 mm switchable probe was used. The data were processed
using the VNMR software (Varian Medical Systems), including
backward linear prediction.
For 1H NMR, the spectrometer conditions usedwere: 60° ﬂip angle,
delay time of 2 s, number of points—5000. Signals were fully relaxed at
these conditions. Tetraethylammonium chloride, dissolved in D2O at
200 μMwas added to each hydrophilic extract as an internal standard
(methyl signal with chemical shift of 1.1 ppmwas used as a standard).
One hundred pulses were collected for each spectrum resulting in
7 min collection time. The peaks were assigned by spiking the RBC
extracts with known standards.
For 31P NMR, the spectrometer conditions were: 60° ﬂip angle,
delay time: 2 s, number of points: 10000, temp.: 20 °C. Signals
were fully relaxed at these conditions. Trimethylphosphate (TMP),
dissolved in CDCl3 at 1 mM was added to each PL extract as an
internal standard (chemical shift—0.5 ppm). Three thousands pulses
were collected for each spectrum resulting in 2.5 h collection time.
2.5. Statistical analysis
All the data were expressed as mean±SD from at least 5 inde-
pendent experiments and were further subjected to the two-tailed
Student's t-test. A P valueb0.05 was considered as statistically
signiﬁcant.
3. Results
3.1. The oxidative status of normal and thalassemic RBCs
Lactate–pyruvate is an important redox couple which reﬂects
the redox state of cells [22]. Using 1H-NMR, we measured the
lactate and pyruvate contents of the hydrophilic extracts of normal
and thalassemic RBCs (Fig. 1). Peaks were assigned by spiking the
RBC extracts with lactate or pyruvate standards (A), and the
assignment was found in agreement with previous reports [23].
The major peaks (doublet at 1.35 ppm for lactate and singlet at
2.40 ppm for pyruvate) were used for quantiﬁcation. The results
showed 3-fold higher lactate, and 5-fold lower pyruvate, content
(Fig. 1B), and 10-fold higher lactate/pyruvate ratio (Fig. 1C) in
thalassemic RBCs compared with normal RBCs. The higher
(Pb0.001, N=10) lactate/pyruvate ratio in thalassemic RBCs sug-
gests their oxidative stress.
The relationship between the lactate/pyruvate ratio and oxida-
tive stress in RBCs was veriﬁed by determining the effects of
oxidants and anti-oxidants. Normal and thalassemic RBCs were
washed, resuspended at 5×106/ml in PBS and incubated for 30 min
at room temperature with the oxidants BHP and H2O2, or the anti-
oxidants Vit. C and NAC. RBCs incubated with PBS alone served as
control. After treatment, RBCs were centrifuged, and their hydro-
philic extracts were analyzed by 1H-NMR (Fig. 1C). The results
indicated that BHP and H2O2 caused 9- and 5-fold increase,
respectively, in lactate/pyruvate ratio in normal RBCs, while both
Vit. C and NAC caused a 4-fold decrease in lactate/pyruvate ratio in
thalassemic RBCs (Pb0.001, N=10).
Fig.1. The oxidative status of normal and thalassemic RBCs. Hydrophilic extracts of RBCs were analyzed by 1H NMR. (A) NMR spectra of thalassemic RBCs (a) and normal RBCs (b). The
lactate and pyruvate peaks were assigned by spiking RBC extracts with pure lactate (c) and pyruvate (d). (B) The contents of lactate and pyruvate were calculated from the peak areas.
Lactate amount was found higher and pyruvate— lower in thalassemic RBCs compared with normal RBCs (Pb0.001, N=10). (C) Normal RBCs were incubated at room temperature for
30 min with oxidants, t-butylhydroxyperoxide (BHP) (1 mM) or H2O2 (5 mM). Thalassemic RBCs were incubated at room temperature for 30 min with the anti-oxidants, vitamin C
(Vit. C) or N-acetyl cysteine (NAC) (both at 1 mM). RBCs incubated with PBS alone served as control. The lactate/pyruvate ratios are presented as the mean±SD of samples obtained
from 10 normal and 10 thalassemic donors, respectively. The results show that oxidants increased the lactate/pyruvate ratio, while anti-oxidants had an opposite effect (Pb0.001).
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Using 31P-NMR, we next studied the PL content of normal and
thalassemic RBCs. The spectra of the lipophilic extracts demonstrated
four major peaks: PC, PI, PE and PS (Fig. 2A). The PLs were assigned
by spiking the RBC extracts with known individual PL standards,
including PE-plasmalogen (PE-plas) and sphingomyelin (SM) as
previously reported [20]. PE-plasmalogen (1-O-1′-alkenyl-2-acylgly-
cero phosphatidylethanolamine) is widely found in mammalian cell
membranes [24,25]. A mixture of the PL standards was used as well.
The results show that the PE peak in the extract included PE-plas. The
quantitative results, calculated in μmol/107 RBCs, showed that
although the total PL amount was similar in thalassemic and normal
RBCs (3.11±0.12 and 3.05±0.09, respectively), their composition
differ (Fig. 2B); the PS and PE were lower (N=5, Pb0.01) in
thalassemic RBCs (0.84±0.12 and 0.55±0.08, respectively) than in
normal RBCs (1.1±0.16 and 0.81±0.09, respectively), while the PCFig. 2. Phospholipids (PLs) in RBCs. (A) 31P-NMR spectra of lipophilic normal and thalasse
phospholipids (PLs). The chemical shifts of the major peaks were veriﬁed by the addition of t
all samples as an internal standard. Peaks were assigned as follows: TMP, PC — phosphatidyl
phosphatidylethanolamine, PE-plas — PE-plasmalogen. The PE peak in the extract include
presented as the mean±SD in samples obtained from 10 normal and 10 thalassemic donors. T
was similar in thalassemic RBCs compared to normal RBCs.was higher (N=5, Pb0.01) in thalassemic (1.60±0.18) compared with
normal (1.21±0.12) RBCs. There was no signiﬁcant difference
(PN0.05) in the PI content between normal (0.49±0.08) and
thalassemic (0.46±0.06) RBCs.
The thalassemic patients studied have been treated by blood
transfusions. Although samples were obtained before transfusion—
at least 3 weeks after the previous transfusion, the patients' blood
contained a mixture of their own RBCs as well as the donors' RBCs.
To determine whether differences in PLs in the patients' samples
were speciﬁc for thalassemic RBCs, the following experiment was
carried out: RBCs from polytransfused thalassemic patients were
washed with iso-osmotic 0.9% NaCl, centrifuged and incubated for
30 min with hypo-osmotic solutions of different NaCl concentra-
tions. Since thalassemic RBCs show resistance to osmotic shock [26],
this procedure selectively lysed normal RBCs and enriched the
mixture with thalassemic RBCs. The non-lysed RBCs were then
extracted and analyzed by 31P-NMR (Fig. 3). The results show a dose-mic RBC extracts and of a normal RBC extract that was spiked with 10 mM standard
he respective pure PL to the extracts. Trimethylphosphate (TMP), at 1 mM, was added to
choline, PI — phosphatidylinositol, SM — sphyngomyelin, PS — phosphatidylserine, PE—
d PE-plas. (B) The contents (in μmole/107 RBCs) of the major PLs were calculated and
he results indicate that PS and PE were lower (Pb0.01), PC was higher (Pb0.01), while PI
Fig. 3. Effect of hypo-osmotic solutions on phospholipids in RBCs from polytransfused
thalassemic patients. RBCs from polytransfused thalassemic patients were washed with
0.9% NaCl, centrifuged and incubated with the indicated NaCl solutions for 30 min. The
non-lysed RBCs were centrifuged, resuspended in 0.9% NaCl, counted and their
hydrophobic extract analyzed by 31P-NMR. Results are presented as μmole/107 RBCs
(mean±SD) in samples obtained from 5 thalassemic donors. The results show a dose-
dependent decrease in PS and increase in PC (Pb0.01, N=5), with no signiﬁcant changes
in PE and PI.
Fig. 5. Kinetic analysis of anti-oxidants effect on RBC phospholipids. Thalassemic
RBCs were incubated with 1 mM vitamin C (Vit. C), N-acetyl cysteine (NAC) or PBS
(Control) at room temperature. At the indicated times, cells were harvested, washed,
extracted and their PS (A) and PC (B) contents were analyzed by 31P NMR. The
results (mean±SD, N=5, Pb0.05) show that PS content was increased and PC was
decreased following treatment with anti-oxidants compared with RBCs incubated
with PBS as a control.
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changes in PE and the PI levels. These results conﬁrmed that the
differences in PL content found in the thalassemic samples were due
to thalassemic RBCs.
3.3. The effects of oxidants and anti-oxidants on phospholipid content
of RBCs
To determine the effects of oxidative stress on PL content, both
normal and thalassemic RBCs were incubated at room temperature for
30 min in PBS containing the oxidants, BHP and H2O2, or the anti-
oxidants, Vit. C and NAC (all at 1 mM, except H2O2— at 5 mM). RBCs
were then extracted and their PLs were measured by 31P NMR.
Although neither oxidants nor anti-oxidants affected total PLs (notFig. 4. Modulation of the phospholipid content in RBCs. Normal and thalassemic
RBCs were washed, redispersed in PBS and incubated at room temperature for
30 min with the oxidants, t-butylhydroxyperoxide (BHP) and H2O2, with the anti-
oxidants, vitamin C (Vit. C), N-acetyl cysteine (NAC), or the aminophospholipid
translocase inhibitor N-ethylmaleimide (NEM) (all at 1 mM, except H2O2— 5 mM).
Lipophilic extracts of RBCs were analyzed by 31P NMR. The results of phosphati-
dylserine (PS) and phosphatidylcholine (PC) (mean±SD, N=5) are shown as mole
percent (%) of total phospholipids (PLs). The results show lower PS, and higher PC
contents in normal and thalassemic RBCs treated with the oxidants (Pb0.05). Anti-
oxidants increased the PS and decreased the PC contents in thalassemic RBCs
(Pb0.05), but not in normal RBCs. NEM treatment decreased the PS and increased
the PC in both normal and thalassemic RBCs (Pb0.01).shown), the results, shown in Fig. 4, demonstrate that oxidants
signiﬁcantly decreased (Pb0.05, N=5) the proportion of PS in normal
and thalassemic RBCs (by 21% and 27%, respectively), and increased
(Pb0.05, N=5) the proportion of PC (by 33% and 14%, respectively).
Anti-oxidants increased by 27% the PS and decreased by 18% the PC
proportions in thalassemic RBCs (Pb0.05, N=5), while no changes
were observed in normal RBCs. The proportions of PE and PI did not
change (data not shown).
Fig. 5 shows a kinetic analysis of the effects of anti-oxidants on the
PS and PC levels in thalassemic RBCs. The RBCs were treated for 6 h
with the above mentioned anti-oxidants (each at 1 mM) and their PS
and PC contents were measured. The results show that the PS content
was increased by 21–48% during the ﬁrst 2 h of antioxidant treatment
and remained constant thereafter. In contrast, PS in thalassemic RBCs
incubated with PBS as a control, was decreased during this time by
about 15%. PC was increased by 20% in control and decreased by about
45% during the ﬁrst 2 h of antioxidant treatment and remained
constant thereafter.
3.4. Phospholipids in plasma of normal and thalassemic donors
We next studied the possibility of oxidative stress induced PL
shedding. PL measurements of plasma separated from normal and
thalassemic blood showed (Fig. 6) that thalassemic plasma contains
2.6-fold more PS and 1.8-fold more PC than normal plasma
(Pb0.001, N=10). Using ﬂow cytometry, it has been previously
shown that the plasma of thalassemic patients has increased
amounts of PS-containing MPs [27]. We therefore separated MPs
from the plasma and analyzed their PLs by 31P-NMR. There was no
difference in total PLs content in MPs (MP-PLs) derived from
normal and thalassemic plasma (not shown). However, the PS
content in MPs puriﬁed from 1 ml thalassemic plasma was 5.6-fold
higher and the PC content was 1.8-fold higher than in normal
plasma MPs (Fig. 6B). The results also indicated that the MPs differ
in their PL composition; the proportion of PS was 3.5-fold higher
and the proportion of PC was 1.7-fold lower in thalassemic than in
normal MPs (Pb0.001, N=10).
Fig. 6. The phospholipid content in the plasma and its microparticles. The plasma from
normal and thalassemic blood samples was separated by centrifugation at 200 g and
then again at 3000 g. Microparticles (MPs) were puriﬁed from the plasma by
centrifugation at 100,000 g, 4 °C for 1 h. The plasma and the puriﬁed MPs were
extracted and analyzed by 31P NMR. The results (mean±SD, N=10) show the PS (A) and
PC (B) contents in 1 ml plasma and its MPs.
Fig. 8. The phospholipid composition in RBC supernatants, and the effects of oxidants
and anti-oxidants. Normal and thalassemic RBCs were washed, re-dispersed in PBS and
incubated at room temperature for 30 min. Supernatants were harvested, extracted and
analyzed by 31P NMR. The results show the content of phospholipids (PLs) (mean±SD)
in supernatants of samples obtained from 5 normal and 5 thalassemic donors (Pb0.01).
The results show increased PS and decreased PC, and no signiﬁcant difference in PI and
PE in supernatants of thalassemic RBCs compared to normal RBCs. (B, C) Normal and
thalassemic RBCs were incubated with the oxidants t-butylhydroxyperoxide (BHP) and
H2O2, the anti-oxidants vitamin C (Vit. C) and N-acetyl cysteine (NAC), and the
aminophpospholipid translocase inhibitor N-ethylmaleimide (NEM) (all at 1 mM,
except H2O2— 5 mM). Supernatants were harvested, extracted and analyzed by 31P
NMR. RBCs incubatedwith PBS served as control. The results (N=5, mean±SD) shown as
mole percent (%) of total PLs show that oxidants increased PS (B) and decreased PC (C)
content in normal and thalassemic RBC supernatants. Anti-oxidants decreased PS and
increased PC in supernatants of thalassemic RBCs, but not of normal RBCs. NEM
treatment increased the PS and decreased the PC in both normal and thalassemic
RBCs (Pb0.05).
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The same analysis was carried out on supernatants obtained
following incubation of RBCs in PBS. Normal and thalassemic RBCs
(109 cells) were washed and incubated in PBS at room temperature.
After 30 min, the supernatants were collected by centrifugation at
200 g, and centrifuged again at 1700 g to remove cell debris. PL
measurements (Fig. 7) show 3-fold more (Pb0.001, N=5) PS (A) and
about 30% less (Pb0.01, N=5) PC (B) in the supernatants of thalassemic
RBCs compared with that of normal ones.
MPs were then puriﬁed from normal and thalassemic RBC
supernatants (Fig 7A and B) and analyzed. The results showed 4.8-
fold more PS and 1.5-fold less PC in thalassemic MPs than in normal
MPs. The MPs also differed in their PL composition; the proportion of
PS was 2-fold higher and the proportion of PC was 2.5-fold lower in
thalassemic than in normal MPs.Fig. 7. The phospholipid content in RBC supernatants and their microparticles. Washed
RBCs were resuspended in PBS at concentration of about 109 RBCs/ml. The normal and
thalassemic RBC supernatants were separated by centrifugation at 200 g and then again
at 3000 g. Microparticles (MPs) were puriﬁed from the supernatants by centrifugation
at 100,000 g, 4 °C for 1 h. The supernatants and the puriﬁed MPs were extracted and
analyzed by 31P NMR. The results (mean±SD, N=5) show the PS (A) and PC (B) contents
in 1 ml of RBC supernatants and their MPs.The PS and PC contents in the supernatant were also measured
following treatment with oxidants (H2O2 or BHP) and anti-oxidants
(NAC and Vit. C) (Fig. 8). Oxidant treatment of normal RBCs (A) caused
a 3-fold increase in PS and a 2-fold decrease in PC. Similar treatment of
thalassemic RBCs (B) increased the PS in their supernatants by 12%
and decreased the PC by 15%. Thalassemic RBCs, but not normal RBCs,
treated with the anti-oxidants, decreased the PS (2.8- and 2.6-fold,
respectively) and increased PC (2.5- and 2.2-fold, respectively) in their
supernatants (Pb0.01, N=5).
In order to rule out the possibility that these results are due to
RBC lysis, hemoglobin (Hb) in the supernatants was measured
using the benzidine procedure [28]. Under the conditions of the
above experiments, only traces of Hb were detected, and no
signiﬁcant difference was found between supernatants obtained
from normal and thalassemic RBCs as well as between treated and
untreated samples.
The involvement of PS externalization in its shedding from RBCs
was studied in experiments with N-ethylmaleimide (NEM)— a speciﬁc
inhibitor of aminophospholipid translocase [29], an enzyme that
translocates PS from the outer membrane leaﬂet back to the inner
leaﬂet [30]. By inhibiting this activity, NEM increases the PS exposed
on the outer leaﬂet, and is expected thereby to increase PS shedding.
Our results showed a 35% decrease (Pb0.01) in normal and
thalassemic RBC PS, respectively (Fig. 4), and N3-fold and 22% increase
(Pb0.05) in their supernatant PS, respectively (Fig. 8).
4. Discussion
We [31] and others [32] have shown that RBCs in β-thalassemia are
under oxidative stress. The membrane is a major target for oxidative
damage, caused, most probably, by interaction of its components with
the unmatched globin chains, and the associated iron, heme, or
hemichromes [32–34]. As a result, the normal PL asymmetry in the
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surface [35]. The exposed PS triggers enhanced erythrophagocytosis
leading to short survival time of RBCs in thalassemia [9,35].
In the present study, we used NMR techniques to analyze RBCs
derived from normal and β-thalassemic donors. Using 1H NMR, we
showed a higher lactate and lower pyruvate content in thalassemic
than normal RBCs (Fig. 1). The lactate/pyruvate ratio has been
previously shown in other cell types to be high under oxidative stress
and that a change in this ratio may be used as an indication of cellular
oxidative status [22,36].
Using 31P NMR spectroscopy, we then analyzed the PL content in
the membranes of RBCs. The results showed more PC and,
unexpectedly, less PS in thalassemic RBCs than in normal RBCs
(Fig. 2). Similar results were obtained in RBCs from heterozygous
thalassemic (Hbbth3/+) mice (data not shown). The NMR technique
does not permit distinction between PS in the inner and outer
membrane leaﬂets, but, since previous reports (using mainly
annexin-V binding) showed more PS-exposing RBCs in thalassemic
compared to normal blood samples [37], our results most probably
reﬂect reduced PS in the inner membrane leaﬂet. Two mechanisms,
which are not mutually exclusive, could explain these data: reduced
production of PS [38,39] and/or loss of PS into the surrounding
extra-cellular milieu (shedding). The high content of PS we found in
the supernatants of thalassemic RBC following in vitro incubation in
PBS (Figs. 7, 8) favors the second mechanism. Additional support to
this mechanism was provided by our ﬁnding that plasma from
thalassemic patients (Fig. 6), as well as Hbbth3/+mice (data not
shown) contain more PS than normal plasma.
RBCs are known to shed membranous particles (termed vesicles
or microparticles) during their senescence [27,40,41]. In addition,
several pathologic RBCs, such as sickle-cell disease, hereditary
spherocytosis, hemolytic elliptocytosis, band 4.1 deﬁciency, and Hb
H disease, have a tendency toward microvesiculation in vitro [41,42].
We studied the nature of the shed PS by purifying MPs from plasma
of normal and thalassemic donors and from supernatants of their
RBCs incubated in PBS. We found that only 10–20% of the shed PS
was associated with MPs. Since PLs are scarcely soluble in water,
one may assume that these PLs are bound to the plasma proteins.
Analysis of PLs in MPs (Fig. 6) showed that the PS content and its
proportion among the PLs were higher in thalassemic than in
normal MPs. The proportion of PS among the PLs (mol%) was higher
in thalassemic MPs and lower in normal MPs compared with their
intact RBCs. These ﬁndings are in agreement with those of Wagner
el al. [42,43] who showed that RBC vesicles from both normal and
thalassemia patients are spectrin-free, but enriched in glycophorin A
and PS compared to their respective intact RBC membranes.
The inﬂuence of oxidative stress on the cellular and secreted PS
was analyzed by studying the effects of oxidants and anti-oxidants.
Using ﬂow cytometry techniques, we have previously shown that
treatment with anti-oxidants alleviated oxidative stress in normal
and thalassemic RBCs, while oxidants increased it in thalassemic
RBCs to a higher extent than in normal RBCs [31]. In the present
study, we showed that normal RBCs treated with oxidants, H2O2
and BHP, decreased their cellular PS and increased their secreted
PS content, thus acquiring a thalassemia-like PL-phenotype. In
contrast, thalassemic RBCs treated with anti-oxidants, Vit. C and
NAC, experienced an opposite outcome (Figs. 4 and 8)— acquiring a
normal-like PL-phenotype. Thus, oxidative stress in RBCs induces
shedding of their PS; a loss which cannot be balanced by increased
biosynthesis. These results are in agreement with previous
observations that most pathological conditions with increased
vesiculation are associated with oxidative stress [44] and data
showing that oxidative stress could induce RBCs to lose part of
their membrane in the form of vesicles [42].
The involvement of PS externalization in its shedding from RBCs
was further suggested in experiments with N-ethylmaleimide (NEM)(Figs. 4, 8). NEM is a speciﬁc inhibitor of aminophospholipid translo-
case [29], an enzyme that translocates PS from the outer membrane
leaﬂet back to the inner leaﬂet [30]. Our results show the NEM
increased PS shedding. This could be due to inhibition of the
translocase activity, leading to increased PS exposure on the outer
leaﬂet, suggesting that externalization is a necessary step in PS
shedding from RBCs. It should be noted, however, that NEM may also
inﬂuence PS externalization and shedding by changing the oxidative
status through scavenging of glutathione [45].
The data demonstrate the transient nature of the external PS on
RBCs. Normally, PS externalization is balanced by internalization
mechanisms which include aminophospholipid translocase [29]. In
thalassemia, these mechanisms fail to counter-balance the excess
exposed PS. Indeed, Muller et al. [46] who compared the inward
movement of PLs in thalassemic vs. normal murine RBCs, found
enhanced movement of PC in thalassemic RBCs (which explained
the increased PC), but not of PS movement. Shedding of
membranous PLs, with increased PS and decreased PC contents
(Figs. 7, 8) relative to the intact RBC (Fig. 4), may modulate the
exposed PS under conditions of oxidative stress. The proportion of
the shed PS (in the supernatant, and in MPs puriﬁed from the
supernatant and from the plasma) out of the total PLs (mol%) was
different than in intact RBCs: it decreased from 29 mol% in intact
normal RBCs to 5–9 mol% following shedding, and increased from
22 mol% to 26–29 mol% following shedding. These were accom-
panied by reciprocal changes in PC, without signiﬁcant changes in
PE and PI and in the total PL content. The changes in shed PS may
be explained by preferential shedding from the outer membrane
leaﬂet which is enriched in PS in thalassemic RBCs.
In conclusion, our data indicate that, in response to oxidative
stress, RBCsmodulate their membrane composition by shedding of PS.
This mechanism might prolong their survival by reducing the
phagocytosis signaling of exposed PS, and by competition for the
macrophage PS-receptor by the circulating PS. The signiﬁcance for RBC
survival and the exact mechanisms involved need further clariﬁcation.
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